| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Skye Bioscience, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 38,000 | $3,825 | $0.0170 | 24 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | 24 Feb 2025 | 1 | $0 | 4 | Chief Medical Officer | 26 Feb 2025, 17:34 |
| SKYE | Skye Bioscience, Inc. | 03 Sep 2024 | 1 | $0 | 4 | Chief Medical Officer | 04 Sep 2024, 18:12 |
| SKYE | Skye Bioscience, Inc. | 03 Sep 2024 | 0 | $0 | 3 | Chief Medical Officer | 04 Sep 2024, 17:25 |